This post was written by Paul Sheives.

On November 19, 2009, FDA completed a coordinated and collaborative international effort intended to curb illegal actions involving medical products sold via the internet. The agency issued 22 warning letters to the operators of these web sites and notified internet service providers and domain name registrars that the web sites were selling products in violation of U.S. law. FDA noted that, in many cases, because of these violations, internet service providers and domain name registrars may have grounds to terminate the websites and suspend the use of domain names.